Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03561259
Title A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Subjects (OPTIMUM)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jubilant DraxImage Inc.
Indications

neuroblastoma

Therapies

131I-MIBG + Vorinostat

131I-MIBG

Age Groups: adult | child | senior
Covered Countries USA


No variant requirements are available.